PRE-WORKSHOP PROGRAMME

The Organising Committee are hosting a series of informative webinars leading up to the 31st International Workshop on HIV Drug Resistance and Treatment Strategies taking place in Cape Town, South Africa from 2 to 4 September 2025. Recordings of these webinars will be made available should permission be obtained from presenters prior to the webinars.


2ND WEBINAR

Title: Clinical Management of Viral Non-Suppression on TLD: A Public Health Approach. Reports from Vietnam, Thailand, Uganda, and South Africa
Date: Wednesday, 9 October 2024
Program:
Moderator: Dr Daniel Kuritzkes | Brigham and Women’s Hospital, USA

  • PEPFAR’s approach to the management of viral non-suppression in the TLD era: Dr Elliot Raizes, CDC.
  • Vietnam: Dr Do Thi Nhan, HIV Treatment Head, Vietnam Authority for HIV/AIDS Control and Dr Vo Trieu Ly, Tropical Disease Hospital, Ho Chi Minh City.
  • Thailand: Dr Opass Putcharoen, Thai AIDS Society Committee and Head of the ID specialists Chulalogkorn Hospital, Bangkok.
  • South Africa: Dr Jeremy Nel, Wits Infectious Diseases Research Institute, Johannesburg.
  • Uganda: Dr Cordelia Katureebe, Uganda Ministry of Health and Dr Francis Ssali, The Joint Clinical Research Centre (JCRC), Kampala Uganda.
  • Panel discussion and Q&A

Watch the recording of the webinar here:

(Please note the 2025 Workshop dates have changed to 2 to 4 September 2025)


1ST WEBINAR

Title: An interim Update
Date: Wednesday, 15 May 2024
Program:
Moderator: Dr Daniel Kuritzkes | Brigham and Women’s Hospital, USA
• Dolutegravir-resistance in the TLD era | Professor Gert van Zyl, Stellenbosch University, South Africa
• Cabotegravir/rilpivirine and other long-acting agents in resource-limited settings | Professor Nick Paton, London School of Hygiene & Tropical Medicine, United Kingdom
• Alternative mechanisms of INSTI-resistance | Roger Paredes, irsiCaixa & Hospital Universitari Germans Trias i Pujol, Spain
• Panel on impact of resistance on treatment strategies| Professor Catherine Orrell, University of Cape Town, South Africa and Dr Lloyd Mulenga, University of Zambia School of Medicine, Zambia

Watch the recording of the webinar here: